Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin is a family of structural proteins forming intermediate filaments, providing mechanical support and integrity to epithelial cells of the skin, hair, and nails; specific types are expressed in different skin layers and stages of differentiation, and mutations cause various skin disorders. The extracellular (intercellular) matrix in skin is a complex network of collagens, glycoproteins (e.g., fibronectin, laminin), and proteoglycans that fills the space between cells, provides structural scaffolding, influences cell behavior, anchors cells, mediates cell signaling, regulates hydration, and plays roles in homeostasis, wound healing, infection, and inflammation. Both keratin and the extracellular matrix are essential to skin structure and function but are biologically and therapeutically distinct categories.
No drugs directly target keratin or the extracellular matrix as a single entity; however, drugs may modulate ECM breakdown (e.g., collagenase degrades matrix proteins; MMP inhibitors prevent matrix degradation).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin (skin type) and Extracellular matrix (skin).